Evidence map›Paper›PMID 42736380›Full record

ArticleScientific reports2026

Retraction Note: Combined chemo-magnetic field-photothermal breast cancer therapy based on porous magnetite nanospheres.

Majid Sharifi, Anwarul Hasan, Nadir Mustafa Qadir Nanakali, Abbas Salihi, Fikry Ali Qadir, Hawzheen A Muhammad, Mudhir Sabir Shekha, Falah Mohammad Aziz, Karwan M Amen, Farrokh Najafi and 2 more

Abstract readRetraction Notice
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Majid SharifiDepartment of Nanotechnology, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran.
Anwarul HasanBiomedical Research Center, Qatar University, 2713, Doha, Qatar. ahasan@qu.edu.qa.
Nadir Mustafa Qadir NanakaliDepartment of Biology, College of Science, Cihan University-Erbil, Kurdistan Region, Iraq.
Abbas SalihiDepartment of Biology, College of Science, Salahaddin University-Erbil, Kurdistan Region, Iraq.
Fikry Ali QadirDepartment of Biology, College of Science, Salahaddin University-Erbil, Kurdistan Region, Iraq.
Hawzheen A MuhammadDepartment of Microbiology, College of Medicine, University of Sulaimani, Sulaimani, Kurdistan Region, Iraq.
Mudhir Sabir ShekhaDepartment of Biology, College of Science, Salahaddin University-Erbil, Kurdistan Region, Iraq.
Falah Mohammad AzizDepartment of Biology, College of Science, Salahaddin University-Erbil, Kurdistan Region, Iraq.
Karwan M AmenDepartment of Medical Analysis, Faculty of Science, Tishk International University, Erbil, Iraq.
Farrokh NajafiDepartment of Biomaterial Engineering, University of Amir-Kabir, Tehran, Iran.
Hasan Yousefi-ManeshDepartment of Pharmacology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Mojtaba FalahatiDepartment of Nanotechnology, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran. mojtaba.falahati@alumni.ut.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42736380
PMCPMC13575215

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.